These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23379893)
1. Effect of early measles vaccination (AIK-C strain) for preterm infants. Ichikawa T; Tsuji A; Fujino M; Kusano R; Sugiyama R; Oomori S; Mori K; Maeyama K; Nakayama T Pediatr Int; 2013 Apr; 55(2):163-8. PubMed ID: 23379893 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants. Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793 [TBL] [Abstract][Full Text] [Related]
3. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586 [TBL] [Abstract][Full Text] [Related]
4. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
5. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial. Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382 [TBL] [Abstract][Full Text] [Related]
6. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À; Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684 [TBL] [Abstract][Full Text] [Related]
7. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds]. Liu BY; Feng ZX; Xu AQ Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090 [TBL] [Abstract][Full Text] [Related]
8. Antibody response after measles immunization. Ariyasriwatana C; Kalayanarooj S; Pattamadilok S J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170 [TBL] [Abstract][Full Text] [Related]
9. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768 [TBL] [Abstract][Full Text] [Related]
10. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months]. Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of maternal measles antibody titers and response to the measles vaccination at the age of 9 months in preterm infants. Ozturk S; Kavuncuoglu S; Ozbek S; Vural M Eur J Pediatr; 2007 Nov; 166(11):1181-2. PubMed ID: 17136351 [No Abstract] [Full Text] [Related]
12. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589 [TBL] [Abstract][Full Text] [Related]
13. Reduced seroconversion to measles in infants given vitamin A with measles vaccination. Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754 [TBL] [Abstract][Full Text] [Related]
14. [The study of countermeasures on measles control in infants]. Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845 [TBL] [Abstract][Full Text] [Related]
15. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006. Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232 [TBL] [Abstract][Full Text] [Related]
17. Antimeasles antibodies in preterm infants during early infancy in Turkey. Gunes T; Koklu E; Ozturk MA; Akcakus M; Kurtoglu S; Cetin N; Koklu S Ann Trop Paediatr; 2007 Mar; 27(1):31-7. PubMed ID: 17469730 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the AIK-C measles vaccine in infants aged <9 months in Vietnam. Hong DT; Hien ND; Thao PTP; Anh DD; Mai HH; Huyen DTT; Huong NL; Phuong BH; Iijima M; Ito T; Nakayama T Vaccine; 2019 Jul; 37(32):4576-4580. PubMed ID: 31174936 [TBL] [Abstract][Full Text] [Related]